Quickstart Highlights

AICAR (5-aminoimidazole-4-carboxamide ribonucleoside) is a research compound that activates AMP-activated protein kinase (AMPK)^[1], earning the nickname “exercise pill” after studies showed sedentary animals given AICAR experienced dramatic endurance improvements^[2]. AICAR is prohibited in sports (WADA classifies it as a metabolic modulator) and is not approved for therapeutic use in humans^[1]. This educational protocol presents a once-daily subcutaneous approach for research purposes only.

• Reconstitute: Add 3.0 mL bacteriostatic water → ~16.7 mg/mL concentration.
• Research dosing range: 1,000–3,000 mcg once daily (conservative gradual approach).
• Easy measuring: At 16.7 mg/mL, 1 unit = 0.01 mL ≈ 167 mcg on a U-100 insulin syringe.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 4 weeks; avoid freeze–thaw cycles.

Protocol Overview

Concise summary of the once-daily research regimen.

• Research Goal: Activate AMPK pathways to mimic exercise-like metabolic effects^[1][6].
• Schedule: Daily subcutaneous injections for 8–12 weeks (research protocols).
• Dose Range: 1,000–3,000 mcg daily (conservative); up to 5,000 mcg in advanced protocols.
• Reconstitution: 3.0 mL per 50 mg vial (~16.7 mg/mL) for precise measurements.
• Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated 2–8 °C (35.6–46.4 °F) for up to 4 weeks^[14].

Dosing Protocol

Suggested gradual titration approach for research.

• Start: 1,000 mcg daily; increase by 1,000 mcg every 2 weeks as tolerated.
• Target: 2,000–3,000 mcg daily by Weeks 3–8 (conservative).
• Advanced: Up to 5,000 mcg daily if supported by protocol design.
• Frequency: Once per day (subcutaneous); maintain consistent AMPK activation^[3].
• Timing: Any consistent time; rotate injection sites daily.

Storage Instructions

Proper storage preserves peptide stability and potency.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable up to 24 months^[14].
• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use bacteriostatic water; stable ~4 weeks^[14].
• Freeze–Thaw: Avoid repeated cycles; consider aliquots for long-term storage at −20 °C (−4 °F) (3–6 months)^[14].
• Allow vials to reach room temperature before opening to minimize condensation.

Important Notes

Practical considerations for research protocols.

• Use new sterile insulin syringes for each injection; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation^[11].
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose, administration time, and site rotation for consistency.
• AICAR is prohibited by WADA and not approved for human therapeutic use^[1].

How This Works

AICAR functions as an AMPK agonist, essentially mimicking an energy-depleted cellular state^[6]. After administration, AICAR enters skeletal muscle and other cells where it is metabolized to ZMP (AICAR monophosphate), an analog of AMP that directly activates AMP-activated protein kinase (AMPK)^[6]. AMPK serves as the master regulator of cellular energy homeostasis, and its activation stimulates glucose uptake and fatty-acid oxidation in muscle while promoting mitochondrial biogenesis to boost cellular energy output^[1][6]. This metabolic shift “tricks” cells into responding as if exercising or fasting, activating pathways that improve energy metabolism and endurance capacity without actual physical activity.

Potential Benefits & Side Effects

Observations from preclinical and limited human research.

• Endurance Enhancement: Sedentary mice treated with AICAR showed a remarkable +44% increase in endurance without training^[2], demonstrating exercise-mimetic effects.
• Metabolic Improvements: Increases mitochondrial enzymes, fatty-acid oxidation capacity, and skeletal muscle glucose uptake^[3][6]; improves insulin sensitivity in animal models.
• Therapeutic Potential: Research suggests potential for diabetic neuropathy protection and metabolic syndrome treatment in animal models^[7].
• Safety Profile: Human trials (acadesine, IV) showed tolerable safety up to 210 mg/kg single dose with only mild, transient side effects^[5]; research subcutaneous doses are a small fraction of this.
• Side Effects: Generally well tolerated in studies; possible mild injection-site reactions (redness, irritation) with subcutaneous use.
• Important: Despite promising preclinical results, AICAR remains experimental; no confirmed clinical benefit in humans has been established, and long-term risks are unknown.

Lifestyle Factors

Complementary strategies for research protocols.

• Maintain a balanced, protein-adequate diet to support metabolic adaptations.
• Combine with structured exercise programs to potentially amplify AMPK-mediated benefits.
• Prioritize sleep quality (7–9 hours) to optimize cellular recovery and energy metabolism.
• Monitor hydration status, especially during endurance activities.

Injection Technique

General subcutaneous guidance from clinical best-practice resources^[11].

• Clean the vial stopper and injection site with alcohol swabs; allow to dry completely^[11].
• Pinch a skinfold at the chosen site; insert the needle at 45–90° angle into subcutaneous tissue^[12].
• Inject slowly and steadily; do not aspirate for subcutaneous injections^[12].
• Wait a few seconds after full injection before withdrawing the needle.
• Rotate sites systematically (abdomen at least 2 inches from navel, outer thighs, back of upper arms) to prevent lipohypertrophy^[11].
• Apply gentle pressure with gauze if minor bleeding occurs; do not rub the injection site^[11].

Recommended Source

We recommend Amino Labs for high-purity Retatrutide (5 mg vials).

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs

References